Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling drug ocrelizumab (Ocrevus) for treating primary progressive
another news portal
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling drug ocrelizumab (Ocrevus) for treating primary progressive
People with diabetes are twice as likely to have depression, a charity backing tailored support says.
An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from
People with diabetes are twice as likely to have depression, a charity backing tailored support says.
It turns out Jay Bhattacharya’s talk, “The End of Free Speech is the End of Science” was really a preview of coming attractions, a mission
One of the persistent themes we confront at SBM is the evolving double-standard in clinical medicine. On the one hand, in mainstream medicine there is
Alexandra Morris said women can be dismissed by doctors when describing symptoms of endometriosis.
Steph Richards’ endometriosis charity work was criticised by former Home Secretary Suella Braverman.
Human-caused climate change has already made heat waves around the world more frequent and intense.
Police say a man carrying a backpack with an AR-style pistol inside has been arrested after walking into Aetna’s headquarters in Connecticut
Two people have died following an “unpredecented” outbreak of meningitis in Kent.
Some social media influencers are pushing products to young gym-goers and students, health experts warn.
An expert in medication abortion describes how mifepristone and misoprostol work and what to expect after using these medications known as the “abortion pill.”
Researchers from the University of Bonn and University Hospital Bonn uncover vital mechanism for survival